Atea Pharmaceuticals Stock Performance

AVIR Stock  USD 4.15  0.13  3.23%   
On a scale of 0 to 100, Atea Pharmaceuticals holds a performance score of 9. The firm shows a Beta (market volatility) of 0.75, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Atea Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Atea Pharmaceuticals is expected to be smaller as well. Please check Atea Pharmaceuticals' maximum drawdown, and the relationship between the information ratio and expected short fall , to make a quick decision on whether Atea Pharmaceuticals' price patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Atea Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain forward indicators, Atea Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
3.23
Five Day Return
6.41
Year To Date Return
19.25
Ten Year Return
(86.32)
All Time Return
(86.32)
1
Atea Pharmaceuticals Inc Q3 2025 Earnings Call Highlights Strategic Advances in HCV ...
11/20/2025
2
Were Keeping An Eye On Atea Pharmaceuticals Cash Burn Rate
12/10/2025
3
Is Atea Pharmaceuticals Inc. stock attractive for ETFs - 2025 Fundamental Recap Community Verified Trade Alerts - ulpravda.ru
12/18/2025
4
Atea Pharmaceuticals Potential Best-In-Class HCV Cure With Pivotal Readouts In 2026 - Seeking Alpha
12/23/2025
5
Atea Pharmaceuticals to highlight strategic priorities for FY26 - Yahoo Finance
01/09/2026
6
Wall Street Recap Will Atea Pharmaceuticals Inc face regulatory challenges - Trade Volume Report Long-Term Investment Growth Plans - baoquankhu1.vn
01/16/2026
7
Spotlight On Atea Pharmaceuticals And 2 Other Noteworthy Penny Stocks
01/23/2026
8
Will Atea Pharmaceuticals Inc. face regulatory challenges - Dividend Hike Weekly Breakout Opportunity Watchlist - mfd.ru
01/30/2026
9
Disposition of 300000 shares by Sommadossi Jean-pierre of Atea Pharmaceuticals at 1.24 subject to Rule 16b-3
02/03/2026
Begin Period Cash Flow143.8 M
Total Cashflows From Investing Activities56.1 M

Atea Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  333.00  in Atea Pharmaceuticals on November 9, 2025 and sell it today you would earn a total of  82.00  from holding Atea Pharmaceuticals or generate 24.62% return on investment over 90 days. Atea Pharmaceuticals is currently generating 0.4248% in daily expected returns and assumes 3.5935% risk (volatility on return distribution) over the 90 days horizon. In different words, 32% of stocks are less volatile than Atea, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Atea Pharmaceuticals is expected to generate 4.39 times more return on investment than the market. However, the company is 4.39 times more volatile than its market benchmark. It trades about 0.12 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Atea Pharmaceuticals Target Price Odds to finish over Current Price

The tendency of Atea Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 4.15 90 days 4.15 
about 1.72
Based on a normal probability distribution, the odds of Atea Pharmaceuticals to move above the current price in 90 days from now is about 1.72 (This Atea Pharmaceuticals probability density function shows the probability of Atea Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Atea Pharmaceuticals has a beta of 0.75. This suggests as returns on the market go up, Atea Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Atea Pharmaceuticals will be expected to be much smaller as well. Additionally Atea Pharmaceuticals has an alpha of 0.3605, implying that it can generate a 0.36 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Atea Pharmaceuticals Price Density   
       Price  

Predictive Modules for Atea Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Atea Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.494.087.67
Details
Intrinsic
Valuation
LowRealHigh
1.374.968.55
Details
Naive
Forecast
LowNextHigh
0.604.207.79
Details
3 Analysts
Consensus
LowTargetHigh
6.987.678.51
Details

Atea Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Atea Pharmaceuticals is not an exception. The market had few large corrections towards the Atea Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Atea Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Atea Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.36
β
Beta against Dow Jones0.75
σ
Overall volatility
0.35
Ir
Information ratio 0.1

Atea Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Atea Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Atea Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Atea Pharmaceuticals had very high historical volatility over the last 90 days
Net Loss for the year was (168.38 M) with loss before overhead, payroll, taxes, and interest of (120.09 M).
Atea Pharmaceuticals currently holds about 684.48 M in cash with (135.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Atea Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Roughly 73.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Disposition of 300000 shares by Sommadossi Jean-pierre of Atea Pharmaceuticals at 1.24 subject to Rule 16b-3

Atea Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Atea Stock often depends not only on the future outlook of the current and potential Atea Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Atea Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding84.3 M
Cash And Short Term Investments454.7 M

Atea Pharmaceuticals Fundamentals Growth

Atea Stock prices reflect investors' perceptions of the future prospects and financial health of Atea Pharmaceuticals, and Atea Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Atea Stock performance.

About Atea Pharmaceuticals Performance

Assessing Atea Pharmaceuticals' fundamental ratios provides investors with valuable insights into Atea Pharmaceuticals' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Atea Pharmaceuticals is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.33)(0.34)
Return On Capital Employed(0.39)(0.41)
Return On Assets(0.33)(0.34)
Return On Equity(0.44)(0.42)

Things to note about Atea Pharmaceuticals performance evaluation

Checking the ongoing alerts about Atea Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Atea Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Atea Pharmaceuticals had very high historical volatility over the last 90 days
Net Loss for the year was (168.38 M) with loss before overhead, payroll, taxes, and interest of (120.09 M).
Atea Pharmaceuticals currently holds about 684.48 M in cash with (135.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Atea Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Roughly 73.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Disposition of 300000 shares by Sommadossi Jean-pierre of Atea Pharmaceuticals at 1.24 subject to Rule 16b-3
Evaluating Atea Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Atea Pharmaceuticals' stock performance include:
  • Analyzing Atea Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Atea Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Atea Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Atea Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Atea Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Atea Pharmaceuticals' stock. These opinions can provide insight into Atea Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Atea Pharmaceuticals' stock performance is not an exact science, and many factors can impact Atea Pharmaceuticals' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Atea Stock Analysis

When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.